MedKoo Cat#: 597590 | Name: Laminin B1 (1363-1383)

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Laminin B1 (1363-1383) is the Residue 1363-1383 of laminin B1 chain, KLQSLDLSAAAQMTCGTPPGA.

Chemical Structure

Laminin B1 (1363-1383)
Laminin B1 (1363-1383)
CAS#112761-58-7

Theoretical Analysis

MedKoo Cat#: 597590

Name: Laminin B1 (1363-1383)

CAS#: 112761-58-7

Chemical Formula: C72H122N20O25S

Exact Mass: 1698.8611

Molecular Weight: 1699.94

Elemental Analysis: C, 50.87; H, 7.23; N, 16.48; O, 23.53; S, 1.89

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Laminin B1 (1363-1383); Yosh-4; Yosh 4; Yosh4;
IUPAC/Chemical Name
(2R,3S,9R,12S,15S,18S,21S,24S,27S)-3-((S)-2-((S)-2-((2-(((S)-1-carboxyethyl)amino)-2-oxoethyl)carbamoyl)pyrrolidine-1-carbonyl)pyrrolidine-1-carbonyl)-27-((2S,5S,8S,11S,14S)-14,18-diamino-8-(3-amino-3-oxopropyl)-5-(hydroxymethyl)-2,11-diisobutyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecanamido)-2-hydroxy-21-(hydroxymethyl)-24-isobutyl-9-(mercaptomethyl)-12,15,18-trimethyl-5,8,11,14,17,20,23,26-octaoxo-4,7,10,13,16,19,22,25-octaazanonacosan-29-oic acid
InChi Key
NOISUCZESHIQOS-WXJFWQIXSA-N
InChi Code
InChI=1S/C72H122N20O25S/c1-33(2)24-43(83-60(104)41(74)16-12-13-21-73)63(107)82-42(19-20-52(75)96)62(106)87-48(31-94)68(112)85-44(25-34(3)4)64(108)86-46(27-55(99)100)66(110)84-45(26-35(5)6)65(109)88-47(30-93)67(111)81-37(8)58(102)79-36(7)57(101)80-38(9)59(103)89-49(32-118)61(105)76-29-54(98)90-56(40(11)95)71(115)92-23-15-18-51(92)70(114)91-22-14-17-50(91)69(113)77-28-53(97)78-39(10)72(116)117/h33-51,56,93-95,118H,12-32,73-74H2,1-11H3,(H2,75,96)(H,76,105)(H,77,113)(H,78,97)(H,79,102)(H,80,101)(H,81,111)(H,82,107)(H,83,104)(H,84,110)(H,85,112)(H,86,108)(H,87,106)(H,88,109)(H,89,103)(H,90,98)(H,99,100)(H,116,117)/t36-,37-,38-,39-,40+,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,56-/m0/s1
SMILES Code
C[C@@H](C(O)=O)NC(CNC([C@H]1N(C([C@H]2N(C([C@H]([C@H](O)C)NC(CNC([C@H](CS)NC([C@H](C)NC([C@H](C)NC([C@H](C)NC([C@H](CO)NC([C@H](CC(C)C)NC([C@H](CC(O)=O)NC([C@H](CC(C)C)NC([C@H](CO)NC([C@H](CCC(N)=O)NC([C@H](CC(C)C)NC([C@H](CCCCN)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCC2)=O)CCC1)=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,699.94 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Siironen J, Vuorio E, Sandberg M, Röyttä M. Expression of type I and III collagen and laminin beta1 after rat sciatic nerve crush injury. J Peripher Nerv Syst. 1996;1(3):209-21. PubMed PMID: 10970111. 2: Nakai M, Mundy GR, Williams PJ, Boyce B, Yoneda T. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res. 1992 Oct 1;52(19):5395-9. PubMed PMID: 1394144. 3: Shao FJ, Cheng J, Ma YJ, Yang Q, Ji D, Wang L. [Study on the effects of human augmenter of liver regeneration on laminin B1 chain gene promoter]. Zhonghua Gan Zang Bing Za Zhi. 2006 Jan;14(1):70-1. Chinese. PubMed PMID: 16420775. 4: Dong S, Landfair J, Balasubramani M, Bier ME, Cole G, Halfter W. Expression of basal lamina protein mRNAs in the early embryonic chick eye. J Comp Neurol. 2002 Jun 3;447(3):261-73. PubMed PMID: 11984820.